Download PDF
Hamostaseologie 1987; 07(03/04): 73-75
DOI: 10.1055/s-0038-1660532
Originalarbeit
Schattauer GmbH

Blutgerinnungsstörung – ein führendes Symptom des Lupus erythematodes

K. Hasler
*   Universitätsklinikum Freiburg, Abt. Innere Medizin I (Direktor: Prof. Dr. G. W. Löhr)
,
H. Engler
*   Universitätsklinikum Freiburg, Abt. Innere Medizin I (Direktor: Prof. Dr. G. W. Löhr)
,
M. Maier
*   Universitätsklinikum Freiburg, Abt. Innere Medizin I (Direktor: Prof. Dr. G. W. Löhr)
,
S. Meske
**   Universitätsklinikum Freiburg, Abt. für Rheumatologie und klinische Immunologie (Direktor: Prof. Dr. H. H. Peter)
,
A. Beck
***   Universitätsklinikum Freiburg, Abt. für Radiologie (Direktor: Prof. Dr. W. Wenz)
› Author Affiliations
Further Information

Publication History

Publication Date:
25 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • LITERATUR

  • 1 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat 1957; 17: 237-46.
    CrossrefPubMedGoogle Scholar
  • 2 Baenkler H W. Immunvasculopathien. Fortschr Med 1982; 100: 1647-50.
    PubMedGoogle Scholar
  • 3 McKluskey R T, Fienberg R. Vasculitis in primary vasculitiden, granulomatoses and connective tissue diseases. Hum Pathol 1983; 14: 305-15.
    CrossrefPubMedGoogle Scholar
  • 4 Dubois L F, Arterberry J D. Gangrene as a manifestation of systemic lupus erythematosus. JAMA 1962; 04: 94-102.
    PubMedGoogle Scholar
  • 5 De Palma G, Moskowitz R W, Holdene W D. Peripheral ischemia and collagen diseases. Arch Surg 1972; 105: 313-8.
    CrossrefPubMedGoogle Scholar
  • 6 Gladstfin G S, Rynes R J, Parhami N, Barholomew L E. Gangrene of a foot secondary to systemic lupus erythematosus with large vessel vasculitis. J Rheumat 1979; 06: 549-53.
    PubMedGoogle Scholar
  • 7 Asherson R A, Morgan S H, Harris E N, Gharavi A E, Krausz T, Hughes G R V. Arterial occlusion causing large bowel infarction a reflection of clotting diathesis in SLE?. Clin Rheumatol 1986; 05: 102-5.
    CrossrefPubMedGoogle Scholar
  • 8 Aberg H, Nilson J M. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors IX and XII. Acta Med Scand 1972; 192: 419-25.
    PubMedGoogle Scholar
  • 9 Asherson R A, Lanham J G, Boey M L, Gharavi A E, Hughes G R V. Renal vein thrombosis and inferior cava thrombosis in systemic lupus erythematosus: association with the »lupus anticoagulant«. Clin Exp Rheumat 1984; 02: 75-9.
    PubMedGoogle Scholar
  • 10 Mintz G, Acevedo-Vasquez E, GuitierrezEspinosa G. Renal vein thrombosis in systemic lupus erythematosus. Frequency and risk factors. Arthritis Rheum 1984; 27: 539-44.
    CrossrefPubMedGoogle Scholar
  • 11 Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985; 15: 254-62.
    PubMedGoogle Scholar
  • 12 Bowie E J W, Thompson J H, Pascuzzi C A, Owen C A. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-30.
    PubMedGoogle Scholar
  • 13 St-Claire W, Jones B, Rogers J S. Deep vein thrombosis and a circulating anticoagulant in systemic lupus erythematosus. AJDC 1981; 135: 230-2.
    PubMedGoogle Scholar
  • 14 Bernstein M L, Salusinski-Sternbach M, Bellefleur M. Thrombotic and hemorrhagic complications in children with the lupus anticoagulant. AJDC 1984; 38: 1132-5.
    PubMedGoogle Scholar
  • 15 Glueck H J, Kant K S, Weiss M A, Poliak V E, Miller M A. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985; 145: 1389-95.
    CrossrefPubMedGoogle Scholar
  • 16 Beckenrigde R T, Moore R D, Ratnoff O D. A study of thrombocytopenia. New criteria for the differentiation of idiopathic thrombocytopenia and thrombocytopenia associated with disseminated lupus erythematosus. Blood 1967; 30: 39-53.
    PubMedGoogle Scholar
  • 17 Warlow R S. Subsets of antibodies to extractable nuclear antigens (ENA) as assayed by ELISA correlate with specific clinical abnormalities in SLE. Scand J Rheumat 1986; 15: 57-67.
    CrossrefPubMedGoogle Scholar
  • 18 Bomalaski S, Green D, Carone F. Oculocutaneous albinism, platelet storage pool disease and progressive lupus nephritis. Arch Intern Med 1983; 143: 809-11.
    CrossrefPubMedGoogle Scholar
  • 19 Rapaport S J, Ames S B, Duvall B J. A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity. Blood 1960; 15: 212-22.
    PubMedGoogle Scholar
  • 20 Gobbi F, Stefanini M. Circulating antiAHG anticoagulant in a patient with lupus erythematosus disseminatus. Acta Haemat 1962; 28: 155-62.
    CrossrefPubMedGoogle Scholar
  • 21 Simone J V, Cornet J A, Abildgaard C F. Acquired von Willebrand’s syndrome in systemic lupus erythematosus. Blood 1968; 31: 806-12.
    PubMedGoogle Scholar
  • 22 Castro O, Leonhard M D, Färber M D, Clyne L P. Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus. Ann Intern Med 1972; 77: 543-8.
    CrossrefPubMedGoogle Scholar
  • 23 Kelsey P R, Stevenson K J, Poller L. The diagnosis of lupus anticoagulants by the activated partial thromboplastine time the central role of phosphatidyl serine. Thromb Haemost 1984; 52: 172-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Poon M C, Saito H, Koopman W J. Precipitating antibody against thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus. Blood 1984; 62: 1309-17.
    PubMedGoogle Scholar
  • 25 Chellingsworth M, Scott D G J. Acute systemic lupus erythematosus with fatal pneumonitis and disseminated intravascular coagulation. Ann Rheum Dis 1985; 44: 67-9.
    CrossrefPubMedGoogle Scholar